nodes	percent_of_prediction	percent_of_DWPC	metapath
Sumatriptan—MAOA—conduct disorder	0.884	1	CbGaD
Sumatriptan—MAOA—Enzymatic degradation of Dopamine by monoamine oxidase—COMT—conduct disorder	0.0105	0.0988	CbGpPWpGaD
Sumatriptan—MAOA—Clearance of dopamine—COMT—conduct disorder	0.0076	0.0714	CbGpPWpGaD
Sumatriptan—HTR3A—Ligand-gated ion channel transport—GABRA2—conduct disorder	0.00585	0.055	CbGpPWpGaD
Sumatriptan—DRD2—Dopamine receptors—DRD4—conduct disorder	0.00468	0.0439	CbGpPWpGaD
Sumatriptan—HTR1F—Serotonin receptors—HTR2A—conduct disorder	0.00362	0.034	CbGpPWpGaD
Sumatriptan—MAOA—Serotonin Transporter Activity—SLC6A4—conduct disorder	0.00355	0.0333	CbGpPWpGaD
Sumatriptan—MAOA—Neurotransmitter Clearance In The Synaptic Cleft—COMT—conduct disorder	0.00347	0.0326	CbGpPWpGaD
Sumatriptan—Naratriptan—MAOA—conduct disorder	0.00288	0.316	CrCbGaD
Sumatriptan—HTR1F—Monoamine GPCRs—DRD4—conduct disorder	0.00247	0.0232	CbGpPWpGaD
Sumatriptan—Rizatriptan—MAOA—conduct disorder	0.00238	0.262	CrCbGaD
Sumatriptan—MAOA—Dopamine metabolism—COMT—conduct disorder	0.00235	0.0221	CbGpPWpGaD
Sumatriptan—HTR1D—Serotonin receptors—HTR2A—conduct disorder	0.00231	0.0217	CbGpPWpGaD
Sumatriptan—HTR1B—Serotonin receptors—HTR2A—conduct disorder	0.00227	0.0213	CbGpPWpGaD
Sumatriptan—Zolmitriptan—MAOA—conduct disorder	0.00218	0.24	CrCbGaD
Sumatriptan—MAOA—Biogenic Amine Synthesis—COMT—conduct disorder	0.0021	0.0197	CbGpPWpGaD
Sumatriptan—HTR1F—Amine ligand-binding receptors—DRD4—conduct disorder	0.00208	0.0195	CbGpPWpGaD
Sumatriptan—HTR1A—Serotonin receptors—HTR2A—conduct disorder	0.00173	0.0162	CbGpPWpGaD
Sumatriptan—Almotriptan—MAOA—conduct disorder	0.00165	0.182	CrCbGaD
Sumatriptan—HTR1F—Monoamine GPCRs—HTR2A—conduct disorder	0.00161	0.0151	CbGpPWpGaD
Sumatriptan—HTR1D—Monoamine GPCRs—DRD4—conduct disorder	0.00158	0.0148	CbGpPWpGaD
Sumatriptan—HTR1B—Monoamine GPCRs—DRD4—conduct disorder	0.00155	0.0145	CbGpPWpGaD
Sumatriptan—DRD2—Nicotine Activity on Dopaminergic Neurons—DRD4—conduct disorder	0.00148	0.0139	CbGpPWpGaD
Sumatriptan—HTR1F—Amine ligand-binding receptors—HTR2A—conduct disorder	0.00135	0.0127	CbGpPWpGaD
Sumatriptan—HTR1D—Amine ligand-binding receptors—DRD4—conduct disorder	0.00133	0.0125	CbGpPWpGaD
Sumatriptan—HTR1B—Amine ligand-binding receptors—DRD4—conduct disorder	0.0013	0.0122	CbGpPWpGaD
Sumatriptan—HTR3A—Ion channel transport—GABRA2—conduct disorder	0.00127	0.0119	CbGpPWpGaD
Sumatriptan—HTR1A—Monoamine GPCRs—DRD4—conduct disorder	0.00118	0.0111	CbGpPWpGaD
Sumatriptan—HTR1F—GPCRs, Other—DRD4—conduct disorder	0.0011	0.0103	CbGpPWpGaD
Sumatriptan—DRD2—Hypothetical Network for Drug Addiction—DRD4—conduct disorder	0.00106	0.00995	CbGpPWpGaD
Sumatriptan—DRD2—Monoamine GPCRs—DRD4—conduct disorder	0.00103	0.00971	CbGpPWpGaD
Sumatriptan—HTR1D—Monoamine GPCRs—HTR2A—conduct disorder	0.00103	0.00967	CbGpPWpGaD
Sumatriptan—HTR1B—Monoamine GPCRs—HTR2A—conduct disorder	0.00101	0.00947	CbGpPWpGaD
Sumatriptan—HTR1A—Amine ligand-binding receptors—DRD4—conduct disorder	0.00099	0.0093	CbGpPWpGaD
Sumatriptan—DRD2—Amine ligand-binding receptors—DRD4—conduct disorder	0.000869	0.00816	CbGpPWpGaD
Sumatriptan—HTR1D—Amine ligand-binding receptors—HTR2A—conduct disorder	0.000866	0.00813	CbGpPWpGaD
Sumatriptan—HTR1B—Amine ligand-binding receptors—HTR2A—conduct disorder	0.000848	0.00796	CbGpPWpGaD
Sumatriptan—HTR3A—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.000831	0.00781	CbGpPWpGaD
Sumatriptan—HTR1A—Monoamine GPCRs—HTR2A—conduct disorder	0.000768	0.00722	CbGpPWpGaD
Sumatriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000729	0.00685	CbGpPWpGaD
Sumatriptan—HTR1F—GPCRs, Other—HTR2A—conduct disorder	0.000715	0.00672	CbGpPWpGaD
Sumatriptan—DRD2—Monoamine GPCRs—HTR2A—conduct disorder	0.000675	0.00634	CbGpPWpGaD
Sumatriptan—HTR1A—Amine ligand-binding receptors—HTR2A—conduct disorder	0.000646	0.00607	CbGpPWpGaD
Sumatriptan—HTR3A—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.000626	0.00588	CbGpPWpGaD
Sumatriptan—DRD2—Amine ligand-binding receptors—HTR2A—conduct disorder	0.000567	0.00533	CbGpPWpGaD
Sumatriptan—HTR1F—GPCR ligand binding—CGA—conduct disorder	0.000555	0.00521	CbGpPWpGaD
Sumatriptan—MAOA—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.000549	0.00516	CbGpPWpGaD
Sumatriptan—HTR1F—G alpha (i) signalling events—DRD4—conduct disorder	0.000513	0.00482	CbGpPWpGaD
Sumatriptan—HTR3A—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.00051	0.00479	CbGpPWpGaD
Sumatriptan—HTR1F—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000476	0.00447	CbGpPWpGaD
Sumatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000466	0.00438	CbGpPWpGaD
Sumatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000456	0.00429	CbGpPWpGaD
Sumatriptan—HTR3A—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000442	0.00415	CbGpPWpGaD
Sumatriptan—MAOA—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.000425	0.00399	CbGpPWpGaD
Sumatriptan—MAOA—Neuronal System—GABRA2—conduct disorder	0.000421	0.00395	CbGpPWpGaD
Sumatriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000408	0.00383	CbGpPWpGaD
Sumatriptan—ABCG2—HIF-2-alpha transcription factor network—EP300—conduct disorder	0.0004	0.00375	CbGpPWpGaD
Sumatriptan—HTR1A—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.000361	0.0034	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR ligand binding—CGA—conduct disorder	0.000355	0.00333	CbGpPWpGaD
Sumatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000348	0.00327	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR ligand binding—CGA—conduct disorder	0.000348	0.00326	CbGpPWpGaD
Sumatriptan—HTR1D—G alpha (i) signalling events—DRD4—conduct disorder	0.000328	0.00308	CbGpPWpGaD
Sumatriptan—HTR1B—G alpha (i) signalling events—DRD4—conduct disorder	0.000321	0.00302	CbGpPWpGaD
Sumatriptan—HTR1F—GPCR downstream signaling—CGA—conduct disorder	0.000314	0.00295	CbGpPWpGaD
Sumatriptan—HTR1F—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000311	0.00292	CbGpPWpGaD
Sumatriptan—HTR1F—GPCR ligand binding—DRD4—conduct disorder	0.000311	0.00292	CbGpPWpGaD
Sumatriptan—DRD2—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000305	0.00287	CbGpPWpGaD
Sumatriptan—HTR1D—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000305	0.00286	CbGpPWpGaD
Sumatriptan—HTR1B—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000298	0.0028	CbGpPWpGaD
Sumatriptan—MAOA—Biological oxidations—COMT—conduct disorder	0.000298	0.0028	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—CGA—conduct disorder	0.000285	0.00268	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.000274	0.00257	CbGpPWpGaD
Sumatriptan—HTR1A—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.000272	0.00255	CbGpPWpGaD
Sumatriptan—HTR3A—SIDS Susceptibility Pathways—EP300—conduct disorder	0.00027	0.00254	CbGpPWpGaD
Sumatriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000266	0.0025	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR ligand binding—CGA—conduct disorder	0.000265	0.00249	CbGpPWpGaD
Sumatriptan—MAOA—Transmission across Chemical Synapses—COMT—conduct disorder	0.000264	0.00248	CbGpPWpGaD
Sumatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000261	0.00245	CbGpPWpGaD
Sumatriptan—MAOA—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.000261	0.00245	CbGpPWpGaD
Sumatriptan—DRD2—Circadian rythm related genes—SLC6A4—conduct disorder	0.000259	0.00243	CbGpPWpGaD
Sumatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000256	0.0024	CbGpPWpGaD
Sumatriptan—HTR1A—G alpha (i) signalling events—DRD4—conduct disorder	0.000245	0.0023	CbGpPWpGaD
Sumatriptan—SLCO1A2—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000244	0.00229	CbGpPWpGaD
Sumatriptan—DRD2—Circadian rythm related genes—DRD4—conduct disorder	0.000244	0.00229	CbGpPWpGaD
Sumatriptan—ABCG2—HIF-1-alpha transcription factor network—EP300—conduct disorder	0.000235	0.00221	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.000234	0.0022	CbGpPWpGaD
Sumatriptan—DRD2—GPCR ligand binding—CGA—conduct disorder	0.000232	0.00218	CbGpPWpGaD
Sumatriptan—HTR1A—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000227	0.00213	CbGpPWpGaD
Sumatriptan—HTR1A—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.000222	0.00208	CbGpPWpGaD
Sumatriptan—DRD2—G alpha (i) signalling events—DRD4—conduct disorder	0.000215	0.00202	CbGpPWpGaD
Sumatriptan—SLCO1B1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000209	0.00196	CbGpPWpGaD
Sumatriptan—HTR1F—GPCR ligand binding—HTR2A—conduct disorder	0.000203	0.0019	CbGpPWpGaD
Sumatriptan—MAOA—Neuronal System—COMT—conduct disorder	0.000202	0.0019	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—CGA—conduct disorder	0.000201	0.00188	CbGpPWpGaD
Sumatriptan—DRD2—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.0002	0.00187	CbGpPWpGaD
Sumatriptan—HTR1D—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000199	0.00187	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR ligand binding—DRD4—conduct disorder	0.000199	0.00187	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—CGA—conduct disorder	0.000196	0.00184	CbGpPWpGaD
Sumatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000195	0.00183	CbGpPWpGaD
Sumatriptan—HTR1B—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000195	0.00183	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR ligand binding—DRD4—conduct disorder	0.000195	0.00183	CbGpPWpGaD
Sumatriptan—ABCG2—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000193	0.00181	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—CGA—conduct disorder	0.000182	0.00171	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—CGA—conduct disorder	0.000178	0.00168	CbGpPWpGaD
Sumatriptan—HTR1F—GPCR downstream signaling—DRD4—conduct disorder	0.000176	0.00165	CbGpPWpGaD
Sumatriptan—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000171	0.00161	CbGpPWpGaD
Sumatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00017	0.0016	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—CGA—conduct disorder	0.000168	0.00158	CbGpPWpGaD
Sumatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000167	0.00157	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—DRD4—conduct disorder	0.00016	0.0015	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—CGA—conduct disorder	0.00015	0.00141	CbGpPWpGaD
Sumatriptan—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000148	0.00139	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR ligand binding—DRD4—conduct disorder	0.000148	0.00139	CbGpPWpGaD
Sumatriptan—MAOA—SIDS Susceptibility Pathways—EP300—conduct disorder	0.000138	0.0013	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—CGA—conduct disorder	0.000136	0.00128	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—WASF1—conduct disorder	0.000135	0.00127	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—CGA—conduct disorder	0.000131	0.00123	CbGpPWpGaD
Sumatriptan—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00013	0.00122	CbGpPWpGaD
Sumatriptan—DRD2—GPCR ligand binding—DRD4—conduct disorder	0.00013	0.00122	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR ligand binding—HTR2A—conduct disorder	0.00013	0.00122	CbGpPWpGaD
Sumatriptan—ABCB1—HIF-1-alpha transcription factor network—EP300—conduct disorder	0.000127	0.00119	CbGpPWpGaD
Sumatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000127	0.00119	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR ligand binding—HTR2A—conduct disorder	0.000127	0.00119	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—CGA—conduct disorder	0.000122	0.00114	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—CGA—conduct disorder	0.000119	0.00112	CbGpPWpGaD
Sumatriptan—HTR1A—SIDS Susceptibility Pathways—EP300—conduct disorder	0.000117	0.0011	CbGpPWpGaD
Sumatriptan—HTR1F—GPCR downstream signaling—HTR2A—conduct disorder	0.000115	0.00108	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—CGA—conduct disorder	0.000113	0.00106	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—DRD4—conduct disorder	0.000112	0.00106	CbGpPWpGaD
Sumatriptan—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000112	0.00105	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—DRD4—conduct disorder	0.00011	0.00103	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CGA—conduct disorder	0.000108	0.00101	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CGA—conduct disorder	0.000105	0.00099	CbGpPWpGaD
Sumatriptan—ABCB1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000104	0.000981	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—CGA—conduct disorder	0.000104	0.000979	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—HTR2A—conduct disorder	0.000104	0.000978	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—DRD4—conduct disorder	0.000102	0.000958	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—DRD4—conduct disorder	9.99e-05	0.000938	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR ligand binding—HTR2A—conduct disorder	9.67e-05	0.000909	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—CGA—conduct disorder	9.65e-05	0.000906	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—DRD4—conduct disorder	9.42e-05	0.000885	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—WASF1—conduct disorder	8.62e-05	0.00081	CbGpPWpGaD
Sumatriptan—DRD2—GPCR ligand binding—HTR2A—conduct disorder	8.49e-05	0.000798	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—WASF1—conduct disorder	8.44e-05	0.000793	CbGpPWpGaD
Sumatriptan—DRD2—Circadian rythm related genes—EP300—conduct disorder	8.42e-05	0.000791	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—DRD4—conduct disorder	8.38e-05	0.000787	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CGA—conduct disorder	8.03e-05	0.000754	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—DRD4—conduct disorder	7.61e-05	0.000715	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—DRD4—conduct disorder	7.36e-05	0.000691	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—HTR2A—conduct disorder	7.33e-05	0.000688	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—HTR2A—conduct disorder	7.18e-05	0.000674	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CGA—conduct disorder	7.05e-05	0.000662	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—DRD4—conduct disorder	6.68e-05	0.000627	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—HTR2A—conduct disorder	6.66e-05	0.000625	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—HTR2A—conduct disorder	6.52e-05	0.000612	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—WASF1—conduct disorder	6.43e-05	0.000604	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—HTR2A—conduct disorder	6.15e-05	0.000577	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—DRD4—conduct disorder	6.03e-05	0.000566	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—DRD4—conduct disorder	5.9e-05	0.000554	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—WASF1—conduct disorder	5.65e-05	0.00053	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—COMT—conduct disorder	5.5e-05	0.000517	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—HTR2A—conduct disorder	5.47e-05	0.000513	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—MAOA—conduct disorder	5.46e-05	0.000513	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	5.43e-05	0.00051	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—conduct disorder	5.3e-05	0.000498	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CGA—conduct disorder	5.22e-05	0.00049	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—COMT—conduct disorder	5.1e-05	0.000479	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—HTR2A—conduct disorder	4.96e-05	0.000466	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—HTR2A—conduct disorder	4.8e-05	0.000451	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—COMT—conduct disorder	4.7e-05	0.000442	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—MAOA—conduct disorder	4.67e-05	0.000439	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—conduct disorder	4.53e-05	0.000425	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—DRD4—conduct disorder	4.49e-05	0.000422	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—HTR2A—conduct disorder	4.36e-05	0.000409	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—COMT—conduct disorder	4.36e-05	0.000409	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—MAOA—conduct disorder	4.32e-05	0.000406	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—DRD4—conduct disorder	3.95e-05	0.000371	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—HTR2A—conduct disorder	3.93e-05	0.000369	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—HTR2A—conduct disorder	3.85e-05	0.000362	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—EP300—conduct disorder	3.26e-05	0.000306	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—HTR2A—conduct disorder	2.93e-05	0.000275	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—HTR2A—conduct disorder	2.57e-05	0.000242	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—EP300—conduct disorder	2.36e-05	0.000222	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—COMT—conduct disorder	2.35e-05	0.000221	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—MAOA—conduct disorder	2.34e-05	0.00022	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—EP300—conduct disorder	2.19e-05	0.000205	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—EP300—conduct disorder	2.08e-05	0.000196	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—EP300—conduct disorder	2.04e-05	0.000192	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—EP300—conduct disorder	2.02e-05	0.000189	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—EP300—conduct disorder	1.87e-05	0.000175	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—EP300—conduct disorder	1.55e-05	0.000146	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—EP300—conduct disorder	1.36e-05	0.000128	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—EP300—conduct disorder	1.01e-05	9.49e-05	CbGpPWpGaD
